New Year's Address 2020

Ahn Jae-hyun, CEO of Boryung Pharmaceutical, "Discovering New Business Ventures Through Bold Investment" View original image


[Asia Economy Reporter Cho Hyun-ui] Ahn Jae-hyun, CEO of Boryung Pharmaceutical, stated on the 2nd, "We will make bold investments to enhance corporate value and discover new future growth businesses."


In his New Year's address, CEO Ahn said, "Let's create a new history through more innovative changes and strong challenges."


Boryung Pharmaceutical has set its management policies for this year as ▲ strengthening profit-centered management ▲ establishing world-class manufacturing competitiveness ▲ equipping future growth engines. CEO Ahn stated, "We will increase development personnel and invest in research and clinical trials for new drugs, improved new drugs, and generics, as well as discover second and third ViGenCells."



He also emphasized on-site management. CEO Ahn said, "I will work alongside employees on the field," adding, "We will strengthen quality management and take proactive measures so that patients can take our medicines with confidence."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing